Invited Speakers (confirmed / alphabetical order)

Björn Clausen, University Medical Center, Mainz, Germany

Dissecting the dendritic cell network in psoriasis-like skin disease

Matthew Collin, Newcastle University, Newcastle upon Tyne, UK

Langerin expression and mutated BRAF in human dendritic cells: more clues about the origin of Langerhans cell histiocytosis

Béhazine Combadière, INSERM, Paris, France

Langerhans cell's pivotal role in tailored immunity to vaccines

Esther de Jong, Academic Medical Center, University of Amsterdam, The Netherlands

Functional specialization of skin dendritic cell subsets

Bertrand Dubois, INSERM, Lyon, France

Langerhans cells dictate skin reactivity to weak contact allergens

Teunis Geijtenbeek, Academic Medical Center, University of Amsterdam, The Netherlands

C-type lectins in infection and immunity

Florent Ginhoux, Singapore Immunology Network (SIgN), Singapore

Ontogeny of dendritic cells

Michael Girardi, Yale University School of Medicine, New Haven, CT, USA

Unintended roles of Langerhans cells in cutaneous carcinogenesis

Muzlifah Haniffa, Newcastle University, Newcastle upon Tyne, UK

Human dendritic cell subsets

Thomas Hieronymus, RWTH Aachen University, Aachen, Germany

Long-term and short-term Langerhans cell homeostasis

Dan Kaplan, University of Minnesota, Minneapolis, MN, USA

Skin dendritic cell subsets and T helper cell phenotype

Adrien Kissenpfennig, Queens University Belfast, Belfast, UK

Can Langerhans cells take the sting out of vaccines?

Eynav Klechevsky, Washington University, St.Louis, MO, USA

What makes human Langerhans cells so special? Lessons learned using systems biology approaches

Keisuke Nagao, Keio University School of Medicine, Tokyo, Japan

Hair follicles regulate immune homeostasis in skin

Frank Nestle, St. John's Institute of Dermatology, King's College, London, UK

Dermal dendritic cells: key sentinels of the skin immune system

Natalija Novak, University of Bonn Medical Center, Bonn, Germany

The role of human Langerhans cells of the oral mucosa and the skin in allergic diseases

Niki Romani, Innsbruck Medical University, Innsbruck, Austria

Wrapping up LC2013: the current status of Langerhans cells, their future and beyond

Knut Schäkel, University of Heidelberg, Germany

Slan (6-sulfo LacNAc) dendritic cells: a pro-inflammatory population of dermal dendritic cells

Georg Stingl, Medical University of Vienna, Vienna, Austria

Langerhans cell research 1973 – 2013 : a journey into uncertainty

Herbert Strobl, Medical University of Vienna, Vienna, Austria

Molecular mechanisms underyling Langerhans cell differentiation

Yvette van Kooyk, Free University Medical Center, Amsterdam, The Netherlands

Glycan-based targeting of vaccines to Langerhans cells and dendritic cells in the skin

James Young, Sloan-Kettering Institute for Cancer Research, New York, NY, USA

Molecular clues to the superiority of human CD34+ HPC-derived Langerhans cells for stimulating CTLs

Additional speakers will be selected from submitted abstracts